-
1
-
-
77955551055
-
American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer
-
PID: 20625130
-
Burstein HJ, Prestrud AA, Seidenfeld J, Anderson H, Buchholz TA, Davidson NE, Gelmon KE, Giordano SH, Hudis CA, Malin J, Mamounas EP, Rowden D, Solky AJ, Sowers MR, Stearns V, Winer EP, Somerfield MR, Griggs JJ (2010) American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Clin Oncol 28(23):3784–3796. doi:10.1200/JCO.2009.26.3756
-
(2010)
J Clin Oncol
, vol.28
, Issue.23
, pp. 3784-3796
-
-
Burstein, H.J.1
Prestrud, A.A.2
Seidenfeld, J.3
Anderson, H.4
Buchholz, T.A.5
Davidson, N.E.6
Gelmon, K.E.7
Giordano, S.H.8
Hudis, C.A.9
Malin, J.10
Mamounas, E.P.11
Rowden, D.12
Solky, A.J.13
Sowers, M.R.14
Stearns, V.15
Winer, E.P.16
Somerfield, M.R.17
Griggs, J.J.18
-
2
-
-
19344364880
-
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
-
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687–1717. doi:10.1016/S0140-6736(05)66544-0
-
(2005)
Lancet
, vol.365
, Issue.9472
, pp. 1687-1717
-
-
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)1
-
3
-
-
0037157603
-
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial
-
COI: 1:CAS:528:DC%2BD38XkslGhsLY%3D, PID: 12090977
-
Baum M, Budzar AU, Cuzick J, Forbes J, Houghton JH, Klijn JG, Sahmoud T (2002) Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet 359(9324):2131–2139
-
(2002)
Lancet
, vol.359
, Issue.9324
, pp. 2131-2139
-
-
Baum, M.1
Budzar, A.U.2
Cuzick, J.3
Forbes, J.4
Houghton, J.H.5
Klijn, J.G.6
Sahmoud, T.7
-
4
-
-
10744223655
-
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer
-
COI: 1:CAS:528:DC%2BD2cXitV2qtbc%3D, PID: 15014181
-
Coombes RC, Hall E, Gibson LJ, Paridaens R, Jassem J, Delozier T, Jones SE, Alvarez I, Bertelli G, Ortmann O, Coates AS, Bajetta E, Dodwell D, Coleman RE, Fallowfield LJ, Mickiewicz E, Andersen J, Lonning PE, Cocconi G, Stewart A, Stuart N, Snowdon CF, Carpentieri M, Massimini G, Bliss JM, van de Velde C (2004) A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 350(11):1081–1092. doi:10.1056/NEJMoa040331
-
(2004)
N Engl J Med
, vol.350
, Issue.11
, pp. 1081-1092
-
-
Coombes, R.C.1
Hall, E.2
Gibson, L.J.3
Paridaens, R.4
Jassem, J.5
Delozier, T.6
Jones, S.E.7
Alvarez, I.8
Bertelli, G.9
Ortmann, O.10
Coates, A.S.11
Bajetta, E.12
Dodwell, D.13
Coleman, R.E.14
Fallowfield, L.J.15
Mickiewicz, E.16
Andersen, J.17
Lonning, P.E.18
Cocconi, G.19
Stewart, A.20
Stuart, N.21
Snowdon, C.F.22
Carpentieri, M.23
Massimini, G.24
Bliss, J.M.25
van de Velde, C.26
more..
-
5
-
-
24744450378
-
Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17
-
COI: 1:CAS:528:DC%2BD2MXpvFKjsrY%3D, PID: 16145047
-
Goss PE, Ingle JN, Martino S, Robert NJ, Muss HB, Piccart MJ, Castiglione M, Tu D, Shepherd LE, Pritchard KI, Livingston RB, Davidson NE, Norton L, Perez EA, Abrams JS, Cameron DA, Palmer MJ, Pater JL (2005) Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17. J Natl Cancer Inst 97(17):1262–1271. doi:10.1093/jnci/dji250
-
(2005)
J Natl Cancer Inst
, vol.97
, Issue.17
, pp. 1262-1271
-
-
Goss, P.E.1
Ingle, J.N.2
Martino, S.3
Robert, N.J.4
Muss, H.B.5
Piccart, M.J.6
Castiglione, M.7
Tu, D.8
Shepherd, L.E.9
Pritchard, K.I.10
Livingston, R.B.11
Davidson, N.E.12
Norton, L.13
Perez, E.A.14
Abrams, J.S.15
Cameron, D.A.16
Palmer, M.J.17
Pater, J.L.18
-
6
-
-
7444259675
-
A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer
-
COI: 1:CAS:528:DC%2BD3sXosl2gtbc%3D, PID: 14551341
-
Goss PE, Ingle JN, Martino S, Robert NJ, Muss HB, Piccart MJ, Castiglione M, Tu D, Shepherd LE, Pritchard KI, Livingston RB, Davidson NE, Norton L, Perez EA, Abrams JS, Therasse P, Palmer MJ, Pater JL (2003) A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 349(19):1793–1802
-
(2003)
N Engl J Med
, vol.349
, Issue.19
, pp. 1793-1802
-
-
Goss, P.E.1
Ingle, J.N.2
Martino, S.3
Robert, N.J.4
Muss, H.B.5
Piccart, M.J.6
Castiglione, M.7
Tu, D.8
Shepherd, L.E.9
Pritchard, K.I.10
Livingston, R.B.11
Davidson, N.E.12
Norton, L.13
Perez, E.A.14
Abrams, J.S.15
Therasse, P.16
Palmer, M.J.17
Pater, J.L.18
-
7
-
-
11444251764
-
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer
-
COI: 1:STN:280:DC%2BD2M%2FhsVartA%3D%3D, PID: 15639680
-
Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF, Hoctin-Boes G, Houghton J, Locker GY, Tobias JS (2005) Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer. Lancet 365(9453):60–62. doi:10.1016/S0140-6736(04)17666-6
-
(2005)
Lancet
, vol.365
, Issue.9453
, pp. 60-62
-
-
Howell, A.1
Cuzick, J.2
Baum, M.3
Buzdar, A.4
Dowsett, M.5
Forbes, J.F.6
Hoctin-Boes, G.7
Houghton, J.8
Locker, G.Y.9
Tobias, J.S.10
-
8
-
-
29544433211
-
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer
-
PID: 16382061
-
Thurlimann B, Keshaviah A, Coates AS, Mouridsen H, Mauriac L, Forbes JF, Paridaens R, Castiglione-Gertsch M, Gelber RD, Rabaglio M, Smith I, Wardley A, Price KN, Goldhirsch A (2005) A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 353(26):2747–2757. doi:10.1056/NEJMoa052258
-
(2005)
N Engl J Med
, vol.353
, Issue.26
, pp. 2747-2757
-
-
Thurlimann, B.1
Keshaviah, A.2
Coates, A.S.3
Mouridsen, H.4
Mauriac, L.5
Forbes, J.F.6
Paridaens, R.7
Castiglione-Gertsch, M.8
Gelber, R.D.9
Rabaglio, M.10
Smith, I.11
Wardley, A.12
Price, K.N.13
Goldhirsch, A.14
-
9
-
-
84874745627
-
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
-
COI: 1:CAS:528:DC%2BC38Xhsl2ju7jM, PID: 23219286
-
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Muller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrutia G, Valentini M, Wang Y, Peto R (2013) Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet 381(9869):805–816. doi:10.1016/S0140-6736(12)61963-1
-
(2013)
Lancet
, vol.381
, Issue.9869
, pp. 805-816
-
-
Davies, C.1
Pan, H.2
Godwin, J.3
Gray, R.4
Arriagada, R.5
Raina, V.6
Abraham, M.7
Medeiros Alencar, V.H.8
Badran, A.9
Bonfill, X.10
Bradbury, J.11
Clarke, M.12
Collins, R.13
Davis, S.R.14
Delmestri, A.15
Forbes, J.F.16
Haddad, P.17
Hou, M.F.18
Inbar, M.19
Khaled, H.20
Kielanowska, J.21
Kwan, W.H.22
Mathew, B.S.23
Mittra, I.24
Muller, B.25
Nicolucci, A.26
Peralta, O.27
Pernas, F.28
Petruzelka, L.29
Pienkowski, T.30
Radhika, R.31
Rajan, B.32
Rubach, M.T.33
Tort, S.34
Urrutia, G.35
Valentini, M.36
Wang, Y.37
Peto, R.38
more..
-
10
-
-
84905841417
-
Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American Society of Clinical Oncology clinical practice guideline focused update
-
PID: 24868023
-
Burstein HJ, Temin S, Anderson H, Buchholz TA, Davidson NE, Gelmon KE, Giordano SH, Hudis CA, Rowden D, Solky AJ, Stearns V, Winer EP, Griggs JJ (2014) Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American Society of Clinical Oncology clinical practice guideline focused update. J Clin Oncol 32(21):2255–2269. doi:10.1200/JCO.2013.54.2258
-
(2014)
J Clin Oncol
, vol.32
, Issue.21
, pp. 2255-2269
-
-
Burstein, H.J.1
Temin, S.2
Anderson, H.3
Buchholz, T.A.4
Davidson, N.E.5
Gelmon, K.E.6
Giordano, S.H.7
Hudis, C.A.8
Rowden, D.9
Solky, A.J.10
Stearns, V.11
Winer, E.P.12
Griggs, J.J.13
-
11
-
-
77957936884
-
Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients
-
PID: 20585090
-
Hershman DL, Kushi LH, Shao T, Buono D, Kershenbaum A, Tsai WY, Fehrenbacher L, Lin Gomez S, Miles S, Neugut AI (2010) Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol 28(27):4120–4128. doi:10.1200/JCO.2009.25.9655
-
(2010)
J Clin Oncol
, vol.28
, Issue.27
, pp. 4120-4128
-
-
Hershman, D.L.1
Kushi, L.H.2
Shao, T.3
Buono, D.4
Kershenbaum, A.5
Tsai, W.Y.6
Fehrenbacher, L.7
Lin Gomez, S.8
Miles, S.9
Neugut, A.I.10
-
12
-
-
84863989435
-
Non-initiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer: the Breast Cancer Quality of Care Study (BQUAL)
-
COI: 1:CAS:528:DC%2BC38XhtVGht7%2FM, PID: 22527111
-
Neugut AI, Hillyer GC, Kushi LH, Lamerato L, Leoce N, Nathanson SD, Ambrosone CB, Bovbjerg DH, Mandelblatt JS, Magai C, Tsai WY, Jacobson JS, Hershman DL (2012) Non-initiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer: the Breast Cancer Quality of Care Study (BQUAL). Breast Cancer Res Treat 134(1):419–428. doi:10.1007/s10549-012-2066-9
-
(2012)
Breast Cancer Res Treat
, vol.134
, Issue.1
, pp. 419-428
-
-
Neugut, A.I.1
Hillyer, G.C.2
Kushi, L.H.3
Lamerato, L.4
Leoce, N.5
Nathanson, S.D.6
Ambrosone, C.B.7
Bovbjerg, D.H.8
Mandelblatt, J.S.9
Magai, C.10
Tsai, W.Y.11
Jacobson, J.S.12
Hershman, D.L.13
-
13
-
-
39149111976
-
Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer
-
COI: 1:CAS:528:DC%2BD1cXis1alsrc%3D, PID: 18180462
-
Partridge AH, LaFountain A, Mayer E, Taylor BS, Winer E, Asnis-Alibozek A (2008) Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol 26(4):556–562
-
(2008)
J Clin Oncol
, vol.26
, Issue.4
, pp. 556-562
-
-
Partridge, A.H.1
LaFountain, A.2
Mayer, E.3
Taylor, B.S.4
Winer, E.5
Asnis-Alibozek, A.6
-
14
-
-
34447285278
-
Lost opportunities: physicians’ reasons and disparities in breast cancer treatment
-
PID: 17577028
-
Bickell NA, LePar F, Wang JJ, Leventhal H (2007) Lost opportunities: physicians’ reasons and disparities in breast cancer treatment. J Clin Oncol 25(18):2516–2521
-
(2007)
J Clin Oncol
, vol.25
, Issue.18
, pp. 2516-2521
-
-
Bickell, N.A.1
LePar, F.2
Wang, J.J.3
Leventhal, H.4
-
15
-
-
0037441639
-
Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer
-
COI: 1:CAS:528:DC%2BD2cXpsVGrtbs%3D, PID: 12586795
-
Partridge AH, Wang PS, Winer EP, Avorn J (2003) Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 21(4):602–606
-
(2003)
J Clin Oncol
, vol.21
, Issue.4
, pp. 602-606
-
-
Partridge, A.H.1
Wang, P.S.2
Winer, E.P.3
Avorn, J.4
-
16
-
-
84860618475
-
Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer
-
COI: 1:CAS:528:DC%2BC38Xmt1Sgs7g%3D, PID: 22331951
-
Henry NL, Azzouz F, Desta Z, Li L, Nguyen AT, Lemler S, Hayden J, Tarpinian K, Yakim E, Flockhart DA, Stearns V, Hayes DF, Storniolo AM (2012) Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer. J Clin Oncol 30(9):936–942. doi:10.1200/JCO.2011.38.0261
-
(2012)
J Clin Oncol
, vol.30
, Issue.9
, pp. 936-942
-
-
Henry, N.L.1
Azzouz, F.2
Desta, Z.3
Li, L.4
Nguyen, A.T.5
Lemler, S.6
Hayden, J.7
Tarpinian, K.8
Yakim, E.9
Flockhart, D.A.10
Stearns, V.11
Hayes, D.F.12
Storniolo, A.M.13
-
17
-
-
79956104201
-
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer
-
COI: 1:CAS:528:DC%2BC3MXjtFSrtrw%3D, PID: 20803066
-
Hershman DL, Shao T, Kushi LH, Buono D, Tsai WY, Fehrenbacher L, Kwan M, Gomez SL, Neugut AI (2011) Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat 126(2):529–537. doi:10.1007/s10549-010-1132-4
-
(2011)
Breast Cancer Res Treat
, vol.126
, Issue.2
, pp. 529-537
-
-
Hershman, D.L.1
Shao, T.2
Kushi, L.H.3
Buono, D.4
Tsai, W.Y.5
Fehrenbacher, L.6
Kwan, M.7
Gomez, S.L.8
Neugut, A.I.9
-
18
-
-
77955244910
-
Medication adherence is a partnership, medication compliance is not
-
PID: 20682408
-
Gould E, Mitty E (2010) Medication adherence is a partnership, medication compliance is not. Geriatr Nurs 31(4):290–298. doi:10.1016/j.gerinurse.2010.05.004
-
(2010)
Geriatr Nurs
, vol.31
, Issue.4
, pp. 290-298
-
-
Gould, E.1
Mitty, E.2
-
19
-
-
84929405050
-
The change from brand-name to generic aromatase inhibitors and hormone therapy adherence for early-stage breast cancer
-
Hershman DL, Tsui J, Meyer J, Glied S, Hillyer GC, Wright JD, Neugut AI (2014) The change from brand-name to generic aromatase inhibitors and hormone therapy adherence for early-stage breast cancer. J Natl Cancer Inst. doi:10.1093/jnci/dju319
-
(2014)
J Natl Cancer Inst
-
-
Hershman, D.L.1
Tsui, J.2
Meyer, J.3
Glied, S.4
Hillyer, G.C.5
Wright, J.D.6
Neugut, A.I.7
-
20
-
-
84927137101
-
Household net worth, racial disparities, and hormonal therapy adherence among women with early-stage breast cancer
-
COI: 1:CAS:528:DC%2BC2MXntVWltLY%3D, PID: 25691670
-
Hershman DL, Tsui J, Wright JD, Coromilas EJ, Tsai WY, Neugut AI (2015) Household net worth, racial disparities, and hormonal therapy adherence among women with early-stage breast cancer. J Clin Oncol 33(9):1053–1059. doi:10.1200/JCO.2014.58.3062
-
(2015)
J Clin Oncol
, vol.33
, Issue.9
, pp. 1053-1059
-
-
Hershman, D.L.1
Tsui, J.2
Wright, J.D.3
Coromilas, E.J.4
Tsai, W.Y.5
Neugut, A.I.6
-
21
-
-
84861183258
-
The Breast Cancer Quality of Care Study (BQUAL): a multi-center study to determine causes for noncompliance with breast cancer adjuvant therapy
-
PID: 22487337
-
Neugut AI, Hillyer GC, Kushi LH, Lamerato L, Nathanson SD, Ambrosone CB, Bovbjerg DH, Mandelblatt JS, Magai C, Tsai WY, Jacobson JS, Hershman DL (2012) The Breast Cancer Quality of Care Study (BQUAL): a multi-center study to determine causes for noncompliance with breast cancer adjuvant therapy. Breast J 18(3):203–213. doi:10.1111/j.1524-4741.2012.01240.x
-
(2012)
Breast J
, vol.18
, Issue.3
, pp. 203-213
-
-
Neugut, A.I.1
Hillyer, G.C.2
Kushi, L.H.3
Lamerato, L.4
Nathanson, S.D.5
Ambrosone, C.B.6
Bovbjerg, D.H.7
Mandelblatt, J.S.8
Magai, C.9
Tsai, W.Y.10
Jacobson, J.S.11
Hershman, D.L.12
-
22
-
-
0023092594
-
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
-
COI: 1:STN:280:DyaL2s7ms1GnsQ%3D%3D, PID: 3558716
-
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383
-
(1987)
J Chronic Dis
, vol.40
, Issue.5
, pp. 373-383
-
-
Charlson, M.E.1
Pompei, P.2
Ales, K.L.3
MacKenzie, C.R.4
-
23
-
-
0027407786
-
The Functional Assessment of Cancer Therapy scale: development and validation of the general measure
-
COI: 1:STN:280:DyaK3s7oslKqsQ%3D%3D, PID: 8445433
-
Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J et al (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579
-
(1993)
J Clin Oncol
, vol.11
, Issue.3
, pp. 570-579
-
-
Cella, D.F.1
Tulsky, D.S.2
Gray, G.3
Sarafian, B.4
Linn, E.5
Bonomi, A.6
Silberman, M.7
Yellen, S.B.8
Winicour, P.9
Brannon, J.10
-
24
-
-
0025957282
-
Patients’ willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation
-
COI: 1:STN:280:DyaK3M7otVOmuw%3D%3D, PID: 2008619
-
Llewellyn-Thomas HA, McGreal MJ, Thiel EC, Fine S, Erlichman C (1991) Patients’ willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation. Soc Sci Med 32(1):35–42
-
(1991)
Soc Sci Med
, vol.32
, Issue.1
, pp. 35-42
-
-
Llewellyn-Thomas, H.A.1
McGreal, M.J.2
Thiel, E.C.3
Fine, S.4
Erlichman, C.5
-
25
-
-
77955489707
-
Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians
-
PID: 20516438
-
Mandelblatt JS, Sheppard VB, Hurria A, Kimmick G, Isaacs C, Taylor KL, Kornblith AB, Noone AM, Luta G, Tallarico M, Barry WT, Hunegs L, Zon R, Naughton M, Winer E, Hudis C, Edge SB, Cohen HJ, Muss H (2010) Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians. J Clin Oncol 28(19):3146–3153. doi:10.1200/JCO.2009.24.3295
-
(2010)
J Clin Oncol
, vol.28
, Issue.19
, pp. 3146-3153
-
-
Mandelblatt, J.S.1
Sheppard, V.B.2
Hurria, A.3
Kimmick, G.4
Isaacs, C.5
Taylor, K.L.6
Kornblith, A.B.7
Noone, A.M.8
Luta, G.9
Tallarico, M.10
Barry, W.T.11
Hunegs, L.12
Zon, R.13
Naughton, M.14
Winer, E.15
Hudis, C.16
Edge, S.B.17
Cohen, H.J.18
Muss, H.19
-
26
-
-
0026092635
-
The MOS social support survey
-
COI: 1:STN:280:DyaK3M3ktVejtw%3D%3D, PID: 2035047
-
Sherbourne CD, Stewart AL (1991) The MOS social support survey. Soc Sci Med 32(6):705–714
-
(1991)
Soc Sci Med
, vol.32
, Issue.6
, pp. 705-714
-
-
Sherbourne, C.D.1
Stewart, A.L.2
-
27
-
-
4243119542
-
Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease
-
Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M, Rowland CR (2004) Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2(12):26
-
(2004)
Health Qual Life Outcomes
, vol.2
, Issue.12
, pp. 26
-
-
Atkinson, M.J.1
Sinha, A.2
Hass, S.L.3
Colman, S.S.4
Kumar, R.N.5
Brod, M.6
Rowland, C.R.7
-
28
-
-
0001294190
-
The Impact of Event Scale—revised
-
Wilson JP, Keane TM, (eds), Guilford Press, New York
-
Weiss DS, Marmar CR (1997) The Impact of Event Scale—revised. In: Wilson JP, Keane TM (eds) Assessing psychological trauma and PTSD. Guilford Press, New York, pp 399–411
-
(1997)
Assessing psychological trauma and PTSD
, pp. 399-411
-
-
Weiss, D.S.1
Marmar, C.R.2
-
29
-
-
0037379943
-
Effects of age on coping and psychological distress in women diagnosed with breast cancer: review of literature and analysis of two different geographical settings
-
COI: 1:STN:280:DC%2BD3s7ls12mtw%3D%3D, PID: 12672514
-
Baider L, Andritsch E, Uziely B, Goldzweig G, Ever-Hadani P, Hofman G, Krenn G, Samonigg H (2003) Effects of age on coping and psychological distress in women diagnosed with breast cancer: review of literature and analysis of two different geographical settings. Crit Rev Oncol Hematol 46(1):5–16
-
(2003)
Crit Rev Oncol Hematol
, vol.46
, Issue.1
, pp. 5-16
-
-
Baider, L.1
Andritsch, E.2
Uziely, B.3
Goldzweig, G.4
Ever-Hadani, P.5
Hofman, G.6
Krenn, G.7
Samonigg, H.8
-
30
-
-
84876593315
-
Racial disparities in posttraumatic stress after diagnosis of localized breast cancer: the BQUAL study
-
PID: 23434900
-
Vin-Raviv N, Hillyer GC, Hershman DL, Galea S, Leoce N, Bovbjerg DH, Kushi LH, Kroenke C, Lamerato L, Ambrosone CB, Valdimorsdottir H, Jandorf L, Mandelblatt JS, Tsai WY, Neugut AI (2013) Racial disparities in posttraumatic stress after diagnosis of localized breast cancer: the BQUAL study. J Natl Cancer Inst 105(8):563–572. doi:10.1093/jnci/djt024
-
(2013)
J Natl Cancer Inst
, vol.105
, Issue.8
, pp. 563-572
-
-
Vin-Raviv, N.1
Hillyer, G.C.2
Hershman, D.L.3
Galea, S.4
Leoce, N.5
Bovbjerg, D.H.6
Kushi, L.H.7
Kroenke, C.8
Lamerato, L.9
Ambrosone, C.B.10
Valdimorsdottir, H.11
Jandorf, L.12
Mandelblatt, J.S.13
Tsai, W.Y.14
Neugut, A.I.15
-
31
-
-
34247897093
-
Interpersonal processes of care survey: patient-reported measures for diverse groups
-
PID: 17489912
-
Stewart AL, Napoles-Springer AM, Gregorich SE, Santoyo-Olsson J (2007) Interpersonal processes of care survey: patient-reported measures for diverse groups. Health Serv Res 42(3 Pt 1):1235–1256. doi:10.1111/j.1475-6773.2006.00637.x
-
(2007)
Health Serv Res
, vol.42
, Issue.3
, pp. 1235-1256
-
-
Stewart, A.L.1
Napoles-Springer, A.M.2
Gregorich, S.E.3
Santoyo-Olsson, J.4
-
32
-
-
0034283816
-
The memorial symptom assessment scale short form (MSAS-SF)
-
COI: 1:STN:280:DC%2BD3cvjsVWrtQ%3D%3D, PID: 10964347
-
Chang VT, Hwang SS, Feuerman M, Kasimis BS, Thaler HT (2000) The memorial symptom assessment scale short form (MSAS-SF). Cancer 89(5):1162–1171
-
(2000)
Cancer
, vol.89
, Issue.5
, pp. 1162-1171
-
-
Chang, V.T.1
Hwang, S.S.2
Feuerman, M.3
Kasimis, B.S.4
Thaler, H.T.5
-
33
-
-
77956191830
-
Quality of life among women recently diagnosed with invasive breast cancer: the pathways study
-
PID: 20140494
-
Kwan ML, Ergas IJ, Somkin CP, Quesenberry CP Jr, Neugut AI, Hershman DL, Mandelblatt J, Pelayo MP, Timperi AW, Miles SQ, Kushi LH (2010) Quality of life among women recently diagnosed with invasive breast cancer: the pathways study. Breast Cancer Res Treat 123(2):507–524. doi:10.1007/s10549-010-0764-8
-
(2010)
Breast Cancer Res Treat
, vol.123
, Issue.2
, pp. 507-524
-
-
Kwan, M.L.1
Ergas, I.J.2
Somkin, C.P.3
Quesenberry, C.P.4
Neugut, A.I.5
Hershman, D.L.6
Mandelblatt, J.7
Pelayo, M.P.8
Timperi, A.W.9
Miles, S.Q.10
Kushi, L.H.11
-
34
-
-
84875986986
-
Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer
-
Bowles EJA, Boudreau DM, Chubak J, Yu O, Fujii M, Chestnut J, Buist DS (2012) Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer. J Oncol Pract 8(6):e149–e157. doi:10.1200/JOP.2012.000543
-
(2012)
J Oncol Pract
, vol.8
, Issue.6
, pp. e149-e157
-
-
Bowles, E.J.A.1
Boudreau, D.M.2
Chubak, J.3
Yu, O.4
Fujii, M.5
Chestnut, J.6
Buist, D.S.7
-
35
-
-
84905568889
-
Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy
-
PID: 24802413
-
Kidwell KM, Harte SE, Hayes DF, Storniolo AM, Carpenter J, Flockhart DA, Stearns V, Clauw DJ, Williams DA, Henry NL (2014) Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy. Cancer 120(16):2403–2411. doi:10.1002/cncr.28756
-
(2014)
Cancer
, vol.120
, Issue.16
, pp. 2403-2411
-
-
Kidwell, K.M.1
Harte, S.E.2
Hayes, D.F.3
Storniolo, A.M.4
Carpenter, J.5
Flockhart, D.A.6
Stearns, V.7
Clauw, D.J.8
Williams, D.A.9
Henry, N.L.10
-
36
-
-
84902545701
-
Adherence to hormone therapy among women with breast cancer
-
PID: 24893670
-
Brito C, Portela MC, de Vasconcellos MT (2014) Adherence to hormone therapy among women with breast cancer. BMC Cancer 14:397. doi:10.1186/1471-2407-14-397
-
(2014)
BMC Cancer
, vol.14
, pp. 397
-
-
Brito, C.1
Portela, M.C.2
de Vasconcellos, M.T.3
-
37
-
-
23744476029
-
The role of patient-physician trust in moderating medication nonadherence due to cost pressures
-
PID: 16087823
-
Piette JD, Heisler M, Krein S, Kerr EA (2005) The role of patient-physician trust in moderating medication nonadherence due to cost pressures. Arch Intern Med 165(15):1749–1755. doi:10.1001/archinte.165.15.1749
-
(2005)
Arch Intern Med
, vol.165
, Issue.15
, pp. 1749-1755
-
-
Piette, J.D.1
Heisler, M.2
Krein, S.3
Kerr, E.A.4
-
38
-
-
77951123003
-
Women’s perceptions and experience of adjuvant tamoxifen therapy account for their adherence: breast cancer patients’ point of view
-
PID: 19507263
-
Pellegrini I, Sarradon-Eck A, Soussan PB, Lacour AC, Largillier R, Tallet A, Tarpin C, Julian-Reynier C (2010) Women’s perceptions and experience of adjuvant tamoxifen therapy account for their adherence: breast cancer patients’ point of view. Psychooncology 19(5):472–479. doi:10.1002/pon.1593
-
(2010)
Psychooncology
, vol.19
, Issue.5
, pp. 472-479
-
-
Pellegrini, I.1
Sarradon-Eck, A.2
Soussan, P.B.3
Lacour, A.C.4
Largillier, R.5
Tallet, A.6
Tarpin, C.7
Julian-Reynier, C.8
-
39
-
-
84879361620
-
Adherence to adjuvant hormone therapy in low-income women with breast cancer: the role of provider-patient communication
-
COI: 1:CAS:528:DC%2BC3sXhs1ahtbk%3D, PID: 23263740
-
Liu Y, Malin JL, Diamant AL, Thind A, Maly RC (2013) Adherence to adjuvant hormone therapy in low-income women with breast cancer: the role of provider-patient communication. Breast Cancer Res Treat 137(3):829–836. doi:10.1007/s10549-012-2387-8
-
(2013)
Breast Cancer Res Treat
, vol.137
, Issue.3
, pp. 829-836
-
-
Liu, Y.1
Malin, J.L.2
Diamant, A.L.3
Thind, A.4
Maly, R.C.5
-
40
-
-
0033398683
-
Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness
-
COI: 1:STN:280:DC%2BD3c7isFantw%3D%3D, PID: 10661603
-
Horne R, Weinman J (1999) Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 47(6):555–567
-
(1999)
J Psychosom Res
, vol.47
, Issue.6
, pp. 555-567
-
-
Horne, R.1
Weinman, J.2
-
41
-
-
84905740378
-
Psychosocial factors in adjuvant hormone therapy for breast cancer: an emerging context for adherence research
-
Van Liew JR, Christensen AJ, de Moor JS (2014) Psychosocial factors in adjuvant hormone therapy for breast cancer: an emerging context for adherence research. J Cancer Surviv Res Pract 8(3):521–531. doi:10.1007/s11764-014-0374-2
-
(2014)
J Cancer Surviv Res Pract
, vol.8
, Issue.3
, pp. 521-531
-
-
Van Liew, J.R.1
Christensen, A.J.2
de Moor, J.S.3
-
42
-
-
4344667475
-
Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer
-
PID: 15310774
-
Fink AK, Gurwitz J, Rakowski W, Guadagnoli E, Silliman RA (2004) Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer. J Clin Oncol 22(16):3309–3315. doi:10.1200/jco.2004.11.064
-
(2004)
J Clin Oncol
, vol.22
, Issue.16
, pp. 3309-3315
-
-
Fink, A.K.1
Gurwitz, J.2
Rakowski, W.3
Guadagnoli, E.4
Silliman, R.A.5
-
43
-
-
70249110823
-
Adjuvant hormonal therapy use among insured, low-income women with breast cancer
-
PID: 19451445
-
Kimmick G, Anderson R, Camacho F, Bhosle M, Hwang W, Balkrishnan R (2009) Adjuvant hormonal therapy use among insured, low-income women with breast cancer. J Clin Oncol 27(21):3445–3451
-
(2009)
J Clin Oncol
, vol.27
, Issue.21
, pp. 3445-3451
-
-
Kimmick, G.1
Anderson, R.2
Camacho, F.3
Bhosle, M.4
Hwang, W.5
Balkrishnan, R.6
-
44
-
-
7644239928
-
Beliefs of chronically ill Japanese patients that lead to intentional non-adherence to medication
-
COI: 1:STN:280:DC%2BD2crht12gtg%3D%3D, PID: 15482384
-
Iihara N, Tsukamoto T, Morita S, Miyoshi C, Takabatake K, Kurosaki Y (2004) Beliefs of chronically ill Japanese patients that lead to intentional non-adherence to medication. J Clin Pharm Ther 29(5):417–424. doi:10.1111/j.1365-2710.2004.00580.x
-
(2004)
J Clin Pharm Ther
, vol.29
, Issue.5
, pp. 417-424
-
-
Iihara, N.1
Tsukamoto, T.2
Morita, S.3
Miyoshi, C.4
Takabatake, K.5
Kurosaki, Y.6
-
45
-
-
33745205622
-
Women’s views on chemoprevention of breast cancer: qualitative study
-
COI: 1:STN:280:DC%2BD2s7jtFCrtQ%3D%3D
-
Heisey R, Pimlott N, Clemons M, Cummings S, Drummond N (2006) Women’s views on chemoprevention of breast cancer: qualitative study. Can Fam Phys 52:624–625
-
(2006)
Can Fam Phys
, vol.52
, pp. 624-625
-
-
Heisey, R.1
Pimlott, N.2
Clemons, M.3
Cummings, S.4
Drummond, N.5
-
46
-
-
70449717270
-
Underuse of breast cancer adjuvant treatment: patient knowledge, beliefs, and medical mistrust
-
PID: 19770368
-
Bickell NA, Weidmann J, Fei K, Lin JJ, Leventhal H (2009) Underuse of breast cancer adjuvant treatment: patient knowledge, beliefs, and medical mistrust. J Clin Oncol 27(31):5160–5167. doi:10.1200/JCO.2009.22.9773
-
(2009)
J Clin Oncol
, vol.27
, Issue.31
, pp. 5160-5167
-
-
Bickell, N.A.1
Weidmann, J.2
Fei, K.3
Lin, J.J.4
Leventhal, H.5
-
47
-
-
70349091350
-
Measuring socioeconomic differences in use of health care services by wealth versus by income
-
PID: 19150899
-
Allin S, Masseria C, Mossialos E (2009) Measuring socioeconomic differences in use of health care services by wealth versus by income. Am J Public Health 99(10):1849–1855. doi:10.2105/AJPH.2008.141499
-
(2009)
Am J Public Health
, vol.99
, Issue.10
, pp. 1849-1855
-
-
Allin, S.1
Masseria, C.2
Mossialos, E.3
-
48
-
-
84856230195
-
Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer
-
COI: 1:CAS:528:DC%2BC38XktFaqsw%3D%3D, PID: 21922245
-
Livaudais JC, Hershman DL, Habel L, Kushi L, Gomez SL, Li CI, Neugut AI, Fehrenbacher L, Thompson B, Coronado GD (2012) Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer. Breast Cancer Res Treat 131(2):607–617. doi:10.1007/s10549-011-1762-1
-
(2012)
Breast Cancer Res Treat
, vol.131
, Issue.2
, pp. 607-617
-
-
Livaudais, J.C.1
Hershman, D.L.2
Habel, L.3
Kushi, L.4
Gomez, S.L.5
Li, C.I.6
Neugut, A.I.7
Fehrenbacher, L.8
Thompson, B.9
Coronado, G.D.10
|